These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28304185)

  • 1. Modulation of transcription factor binding and epigenetic regulation of the MLH1 CpG island and shore by polymorphism rs1800734 in colorectal cancer.
    Savio AJ; Bapat B
    Epigenetics; 2017 Jun; 12(6):441-448. PubMed ID: 28304185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dynamic DNA methylation landscape of the
    Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B
    Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polymorphic variant rs1800734 influences methylation acquisition and allele-specific TFAP4 binding in the MLH1 promoter leading to differential mRNA expression.
    Thomas R; Trapani D; Goodyer-Sait L; Tomkova M; Fernandez-Rozadilla C; Sahnane N; Woolley C; Davis H; Chegwidden L; Kriaucionis S; Maughan T; Leedham S; Palles C; Furlan D; Tomlinson I; Lewis A
    Sci Rep; 2019 Sep; 9(1):13463. PubMed ID: 31530880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLH1 region polymorphisms show a significant association with CpG island shore methylation in a large cohort of healthy individuals.
    Savio AJ; Lemire M; Mrkonjic M; Gallinger S; Zanke BW; Hudson TJ; Bapat B
    PLoS One; 2012; 7(12):e51531. PubMed ID: 23240038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF
    Fennell LJ; Jamieson S; McKeone D; Corish T; Rohdmann M; Furner T; Bettington M; Liu C; Kawamata F; Bond C; Van De Pols J; Leggett B; Whitehall V
    BMC Cancer; 2018 Jan; 18(1):35. PubMed ID: 29304767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer.
    de Vogel S; Wouters KA; Gottschalk RW; van Schooten FJ; de Goeij AF; de Bruïne AP; Goldbohm RA; van den Brandt PA; Weijenberg MP; van Engeland M
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3086-96. PubMed ID: 19843671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MLH1 polymorphism rs1800734 and risk of endometrial cancer with microsatellite instability.
    Russell H; Kedzierska K; Buchanan DD; Thomas R; Tham E; Mints M; Keränen A; Giles GG; Southey MC; Milne RL; Tomlinson I; Church D; Spurdle AB; O'Mara TA; Lewis A
    Clin Epigenetics; 2020 Jul; 12(1):102. PubMed ID: 32641106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for heritable predisposition to epigenetic silencing of MLH1.
    Chen H; Taylor NP; Sotamaa KM; Mutch DG; Powell MA; Schmidt AP; Feng S; Hampel HL; de la Chapelle A; Goodfellow PJ
    Int J Cancer; 2007 Apr; 120(8):1684-8. PubMed ID: 17230510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haplotype defined by the MLH1-93G/A polymorphism is associated with MLH1 promoter hypermethylation in sporadic colorectal cancers.
    Miyakura Y; Tahara M; Lefor AT; Yasuda Y; Sugano K
    BMC Res Notes; 2014 Nov; 7():835. PubMed ID: 25421847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the
    Morak M; Ibisler A; Keller G; Jessen E; Laner A; Gonzales-Fassrainer D; Locher M; Massdorf T; Nissen AM; Benet-Pagès A; Holinski-Feder E
    J Med Genet; 2018 Apr; 55(4):240-248. PubMed ID: 29472279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for genomic fragments that are methylated specifically in colorectal carcinoma with a methylated MLH1 promoter.
    Koinuma K; Kaneda R; Toyota M; Yamashita Y; Takada S; Choi YL; Wada T; Okada M; Konishi F; Nagai H; Mano H
    Carcinogenesis; 2005 Dec; 26(12):2078-85. PubMed ID: 16033773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The non-coding variant rs1800734 enhances DCLK3 expression through long-range interaction and promotes colorectal cancer progression.
    Liu NQ; Ter Huurne M; Nguyen LN; Peng T; Wang SY; Studd JB; Joshi O; Ongen H; Bramsen JB; Yan J; Andersen CL; Taipale J; Dermitzakis ET; Houlston RS; Hubner NC; Stunnenberg HG
    Nat Commun; 2017 Feb; 8():14418. PubMed ID: 28195176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.
    Wang T; Liu Y; Sima L; Shi L; Wang Z; Ni C; Zhang Z; Wang M
    PLoS One; 2012; 7(11):e50449. PubMed ID: 23226285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation changes that precede onset of dysplasia in advanced sessile serrated adenomas.
    Liu C; Fennell LJ; Bettington ML; Walker NI; Dwine J; Leggett BA; Whitehall VLJ
    Clin Epigenetics; 2019 Jun; 11(1):90. PubMed ID: 31200767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary constitutional MLH1 epimutations: a focal epigenetic event.
    Dámaso E; Castillejo A; Arias MDM; Canet-Hermida J; Navarro M; Del Valle J; Campos O; Fernández A; Marín F; Turchetti D; García-Díaz JD; Lázaro C; Genuardi M; Rueda D; Alonso Á; Soto JL; Hitchins M; Pineda M; Capellá G
    Br J Cancer; 2018 Oct; 119(8):978-987. PubMed ID: 30283143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer.
    Hitchins MP; Lin VA; Buckle A; Cheong K; Halani N; Ku S; Kwok CT; Packham D; Suter CM; Meagher A; Stirzaker C; Clark S; Hawkins NJ; Ward RL
    Cancer Res; 2007 Oct; 67(19):9107-16. PubMed ID: 17909015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and promoter DNA methylation of MLH1 in colorectal cancer and lung cancer.
    Ma Y; Chen Y; Petersen I
    Pathol Res Pract; 2017 Apr; 213(4):333-338. PubMed ID: 28214209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of a -35 kb Enhancer Impairs CTCF Binding and
    Liu Q; Thoms JAI; Nunez AC; Huang Y; Knezevic K; Packham D; Poulos RC; Williams R; Beck D; Hawkins NJ; Ward RL; Wong JWH; Hesson LB; Sloane MA; Pimanda JE
    Clin Cancer Res; 2018 Sep; 24(18):4602-4611. PubMed ID: 29898989
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors.
    Levine AJ; Phipps AI; Baron JA; Buchanan DD; Ahnen DJ; Cohen SA; Lindor NM; Newcomb PA; Rosty C; Haile RW; Laird PW; Weisenberger DJ
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):68-75. PubMed ID: 26512054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.